The Onder Law Firm Announces Creation of Lipitor Diabetes Lawsuit Center Website

Lawyers handling Lipitor diabetes cases launch Lipitor Diabetes Lawsuit Center website and offer free Lipitor diabetes lawsuit case review.

Thursday, June 27, 2013 - The Onder Law Firm, attorneys with experience and expertise at handling complex litigation involving medical devices and pharmaceutical products, has recently launched a Lipitor Diabetes Lawsuit Center website offering the general public information about the FDA Lipitor diabetes warning and the link between statin use and increased risk of diabetes. The FDA issued a Safety Warning on February 28, 2012 (fda.gov/drugs/drugsafety/ucm293101.htm) regarding Lipitor and other statins and their potential for increasing blood sugar levels in users, which can result in diabetes. The warning came as a result of multiple medical studies, including the results of a study published in 2010 in the Lancet medical journal (reuters.com/article/2012/02/28/us-fda-statins-idUSTRE81R1O220120228), concluded that Lipitor and other statins can increase the risk of diabetes by 9%. The FDA Lipitor Diabetes Warning also referenced a Women‘s Health Initiative study that found an increased risk of diabetes in post-menopausal women using a statin, regardless of potency.

Statin drugs are used to lower the body‘s production of bad cholesterol by inhibiting the production of an enzyme in the liver. Lowering a person‘s bad cholesterol reduces the risk of cardiac disease and heart attack. Lipitor, which is manufactured by the multinational pharmaceutical corporation Pfizer, Inc., was first approved by the FDA for general use in 1996 and has since become the world‘s all-time biggest selling prescription medicine with sales of more than $130 billion.

The Onder Law Firm is currently investigating cases in which persons used Lipitor and were later diagnosed with diabetes. The attorneys at The Onder Law Firm have represented thousands of Americans in lawsuits against pharmaceutical, medical device manufacturers and other multinational conglomerates in lawsuits ranging from products liability for manufacture of defective or dangerous products to deceptive advertising practices. The firm‘s Lipitor lawyers are speaking with those who feel they may need legal representation in this matter, or at the least guidance in what options may be available to them, nationwide. Those affected may receive a no-cost, no-obligation consultation with an actual attorney by visiting the firm‘s Lipitor diabetes website. The Onder Law Firm welcomes Lipitor and other statin lawsuit inquiries from law firms in regards to handling them or working as co-counsel.

Other Lipitor Lawsuit Attorney News Releases:

Ad